Risk-based lung cancer screening in heavy smokers: a benefit–harm and cost-effectiveness modeling study

Yin Liu,Huifang Xu,Lihong Lv,Xiaoyang Wang,Ruihua Kang,Xiaoli Guo,Hong Wang,Liyang Zheng,Hongwei Liu,Lanwei Guo,Qiong Chen,Shuzheng Liu,Youlin Qiao,Shaokai Zhang
DOI: https://doi.org/10.1186/s12916-024-03292-4
IF: 9.3
2024-02-22
BMC Medicine
Abstract:Annual screening through low-dose computed tomography (LDCT) is recommended for heavy smokers. However, it is questionable whether all individuals require annual screening given the potential harms of LDCT screening. This study examines the benefit–harm and cost-effectiveness of risk-based screening in heavy smokers and determines the optimal risk threshold for screening and risk-stratified screening intervals.
medicine, general & internal
What problem does this paper attempt to address?